Levocetirizine dihydrochloride

From WikiMD's Wellness Encyclopedia

(Redirected from Xyzal)

What is Levocetirizine dihydrochloride?[edit | edit source]

Levocetirizine structure
Levocetirizine 3D ball



What are the uses of this medicine?[edit | edit source]

Levocetirizine dihydrochloride tablets are indicated for:


How does this medicine work?[edit | edit source]

  • The dihydrochloride salt form of the active levorotatory enantiomer of cetirizine, levocetirizine; a third generation, non-sedating, selective histamine H1 receptor antagonist, with antihistamine, anti-inflammatory and potential anti-angiogenic activities.
  • Levocetirizine competes with endogenous histamine for binding at peripheral H1-receptor sites on the effector cell surface.
  • This prevents the negative symptoms associated with histamine release and an allergic reaction.
  • In addition, as histamine plays an important role in angiogenesis during an allergic inflammatory reaction, blocking the action of histamine may modulate the expression of proangiogenic factors and thus may prevent angiogenesis.
  • As a third-generation histamine H1 receptor antagonist, levocetirizine has fewer side effects than most second-generation antihistamines.


Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients who:

  • known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine.
  • end-stage renal disease (CLCR < 10 mL/min) and patients undergoing hemodialysis.
  • Children 6 months to 11 years of age with impaired renal function.


What drug interactions can this medicine cause?[edit | edit source]

  • No in vivo drug-drug interaction studies have been performed with levocetirizine.


Is this medicine FDA approved?[edit | edit source]

  • Levocetirizine was approved for medical use in the United States in 2007.


How should this medicine be used?[edit | edit source]

Recommended dosage:

  • Adults and children 12 years of age and older: 5 mg once daily in the evening.
  • Children 6 to 11 years of age: 2.5 mg once daily in the evening.


Renal Impairment:

  • Adjust the dose in patients 12 years of age and older with decreased renal function.
  • Mild renal impairment (creatinine clearance [CLCR] = 50-80 mL/min): a dose of 2.5 mg once daily is recommended;
  • Moderate renal impairment (CLCR = 30-50 mL/min): a dose of 2.5 mg once every other day is recommended;
  • Severe renal impairment (CLCR = 10-30 mL/min): a dose of 2.5 mg twice weekly (administered once every 3-4 days) is recommended;
  • End-stage renal disease patients (CLCR < 10 mL/min) and patients undergoing hemodialysis should not receive levocetirizine dihydrochloride tablets.


Administration:

  • Levocetirizine dihydrochloride tablets are available as 5 mg breakable (scored) tablets, allowing for the administration of 2.5 mg, if needed.
  • Levocetirizine dihydrochloride tablets can be taken without regard to food consumption.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Immediate release breakable (scored) tablets, 5 mg

This medicine is available in fallowing brand namesː

  • Xyzal ; Xyzal Allergy 24 Hr


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:


What special precautions should I follow?[edit | edit source]

  • Avoid engaging in hazardous occupations requiring complete mental alertness such as driving or operating machinery when taking levocetirizine dihydrochloride tablets.
  • Avoid concurrent use of alcohol or other central nervous system depressants with levocetirizine dihydrochloride tablets.
  • Cetirizine and levocetirizine have been linked to rare, isolated instances of clinically apparent acute liver injury.


What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:

Management of overdosage:

  • There is no known specific antidote to levocetirizine dihydrochloride tablets.
  • Should overdose occur, symptomatic or supportive treatment is recommended.
  • Levocetirizine dihydrochloride tablets are not effectively removed by dialysis, and dialysis will be ineffective unless a dialyzable agent has been concomitantly ingested.


Can this medicine be used in pregnancy?[edit | edit source]

  • There are no adequate and well-controlled studies in pregnant women.
  • Pregnancy Category B


Can this medicine be used in children?[edit | edit source]

  • The safety of levocetirizine dihydrochloride tablets 5 mg once daily was evaluated in pediatric patients 6 to 12 years of age.


What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredient:

  • LEVOCETIRIZINE DIHYDROCHLORIDE

Inactive ingredients:

  • CELLULOSE, MICROCRYSTALLINE
  • LACTOSE MONOHYDRATE
  • MAGNESIUM STEARATE
  • HYPROMELLOSES
  • TITANIUM DIOXIDE
  • POLYETHYLENE GLYCOL 400


Who manufactures and distributes this medicine?[edit | edit source]

Manufactured by:

  • Rottendorf Pharma GmbH
  • Ennigerloh, Germany
  • Made in Germany

Distributed by:

  • Perrigo
  • Allegan, MI


What should I know about storage and disposal of this medication?[edit | edit source]

  • Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F).


Levocetirizine dihydrochloride Resources
Wikipedia

First Generation Antihistamines

Second Generation Antihistamines


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju